Skip to content

Placebo, 5 mg, 3 months

2 trials

Sponsors

Vice Chancellor for Research and Technology, Ahvaz Jundishapur University of Medical Sciences

Conditions

Nonalcoholic fatty liver disease (NAFLD). nonalcoholic steatohepatitismetabolic syndrome. Nutritional and metabolic disorders in diseases classified elsewhere